NovaGo Therapeutics
PrivateLast Round
Series B
Sep 2, 2026
Total Funding Raised
$41M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
NovaGo Therapeutics is a biotechnology company that develops human antibody therapeutics to promote nerve growth and regeneration for conditions like spinal cord injury and stroke.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovaGo Therapeutics Comparables
Compare NovaGo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReNetX Bio | 87% | |
| CSPC Pharmaceutical Group Limited | 77% | |
| Axonis Therapeutics | 77% | |
NovaGo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 2, 2026 | ||||
| Series A | Mar 4, 2019 | ||||
| Grant | Jan 1, 2015 |
NovaGo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wings for Life Foundation | Series B |
| Wyss Zurich | Grant |
| Pureos Bioventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2026
$30M round led by Neurimmune AG and Pureos Bioventures.
- Jun 19, 2026
Monthly visitors increased 89% MoM.
NovaGo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NovaGo Therapeutics's valuation, stock price, and market status.